Gokul Nukala, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 S Teel Dr, Devine, TX 78016 Phone: 830-455-5071 Fax: 830-455-5073 |
Mr. Onis Corwin Wiemers, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 S Teel Dr, P.o. Drawer-r, Devine, TX 78016 Phone: 830-663-2224 Fax: 830-665-3053 |
Dr. Christopher Anthony Vasquez, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 175 Interstate 35 N, Devine, TX 78016 Phone: 830-664-5964 |
Tania Cantin Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 175 Interstate 35 N, Devine, TX 78016 Phone: 830-663-5964 |
Antoinette Grice, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 175 Interstate 35 N, Devine, TX 78016 Phone: 830-663-5964 |
News Archive
Progenika Biopharma S.A., a pioneer in the field of personalized medicine, announced today that it has obtained the CE Mark allowing the sale in Europe of its LPLchip(R), the first DNA chip to detect mutations in the lipoprotein lipase (LPL) gene.
New research proves the validity of one of the most promising approaches for combating Alzheimer's disease (AD) with medicines that treat not just some of the symptoms, but actually stop or prevent the disease itself, scientists are reporting. The study, in the journal ACS Medicinal Chemistry Letters, also identifies a potential new oral drug that the scientists say could lead the way.
A group of the Lomonosov Moscow State University scientists, together with their colleagues from the Institute of Molecular Biology, Russian Academy of Sciences and the King's College London, succeeded in sorting out the mechanism of Alzheimer's disease development and possibly distinguished its key trigger.
According to a new report by researchers from UK, the population of Papua New Guinea has the greatest linguistic and genetic diversity. The language differences across the bends of the river Sepik are baffling and reflect and underlying genetic diversity that was until now not fully appreciated. The study report is published today 15th of September 2017 in the journal Science.
In the current issue of Psychotherapy and Psychosomatics a randomized controlled trial indicates that group therapy may affect the course of bipolar disorder. This study evaluated the effectiveness of adjunctive cognitive behavioral group therapy to prevent recurrence of episodes in 50 euthymic patients with bipolar disorder types I and II followed up for at least 12 months in an outpatient service and whose disease was in remission.
› Verified 6 days ago